Medicare has historically not covered weight-loss-only indications, though the 2026 GLP-1 Bridge program provides temporary access to Foundayo at $50/month through December
Theres also a significant and growing number of people who turn to these drugs for what I refer to as vanity pounds typically a relatively healthy person with maybe an extra 10 or 20 pounds theyd like to lose, but nothing thats posing any notable health risks
What is more, no clear trend for a change in pharmacokinetics was evident across groups with increasing renal dysfunction 12 that allowed us to administer the same dose of the drug and the same blood sampling time points in patients with different degree of renal impairment who were included in our study
Mitochondrion 69:147158 Egner JM, Nolden KA, Harwig MC, Bonate RP, De Anda J, Tessmer MH, Noey EL, Ihenacho UK, Liu Z, Peterson FC, Wong GC (2022) Structural studies of human fission protein FIS1 reveal a dynamic region important for GTPase DRP1 recruitment and mitochondrial fission
